Partner with us
Studies
/
Response of an Infant With Presumed Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) to Ketone Supplementation
Human other
2026

Response of an Infant With Presumed Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) to Ketone Supplementation

Key finding
An infant with presumed MADD showed marked improvement in severe cardiac dysfunction with ketone supplementation, with near-normal cardiac function and biochemical profiles sustained over 3.5 years.
What the study did

This case report describes an infant with a clinical and biochemical diagnosis of multiple acyl-CoA dehydrogenase deficiency (MADD) who received ketone supplementation. Severe cardiac dysfunction improved markedly, and near-normal cardiac function and biochemical profiles were sustained over 3.5 years. Genome sequencing did not identify causative variants, but RNA sequencing showed reduced ETFB transcript levels and western blot analysis showed decreased ETFB protein levels.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB